Radiation therapy technology is advancing rapidly, with new linear accelerators (linacs) entering the market while industry leaders advance their systems. With so many options available, how can medical facilities make the best choice? Despite new developments, the Varian TrueBeam remains…
At ASTRO this year, Linax Technologies will be showcasing their training programs designed to help engineers service and support linear accelerators and provide physicists with tools to improve clinic efficiency. John Vano, President of Radiology Oncology Systems (ROS), sits down…
John Vano, President of Radiology Oncology Systems, had the opportunity to sit down with Mike Cogswell, CEO of MagnetTx, to discuss ASTRO 2024. Mike is a major player in the radiation oncology space and has helped launch many startups in…
Primum is a new company that helps oncologists, especially those in rural hospitals and clinics, connect with expert peers to make better-informed decisions, especially about complex cases. We sat down with Cory Zankowski, CEO of Primum, to learn more about…
ASTRO, the world’s premier radiation oncology conference, was held in San Diego, California last week. One the second day of the conference, Paul Ziegler, the CEO of ViewRay, sent out a communication letting everyone know that all hopes to keep…
For this installment of our interview series with leaders in the field of radiation oncology, we spoke with Dr. Gino Fallone. The inventor of MagnetTx’s new Aurora-RT linear accelerator, he serves as Professor and Director of the Division of Medical…
Advancements in linear accelerator technology and software-controlled radiation treatment have had a tremendous positive impact on patient outcomes and on the practice of radiation oncology. However, these advancements have also made the commissioning process for linear accelerators more complex. In…
There is a buzz in the radiotherapy world about a new linear accelerator in the works from Siemens Healthineer’s Varian Division. The TrueBeam will be 12 years old next year, and a new, dual-energy model from the world’s top linac…
We’re at an exciting moment in cancer research: New advances in precision medicine, immunotherapy, and epigenetics hold real promise to produce breakthroughs in research and treatment. However, these cutting-edge research avenues require substantial funding, and more support is needed to…
Over the past several years, a number of new radiotherapy devices have been developed, each offering unique features and benefits. If you are a clinician seeking to purchase a new linear accelerator, the choices are daunting. In the U.S. radiation…